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served that many cells lining the lateral ventricle were
positive for Pak1T212(PO4), especially during the early
stages of development. At mouse embryonic stage 12
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MRC Centre (E12), the cortical region primarily consists of proliferat-
ing neuroepithelial cells in an area termed the ventricularNew Hunt’s House
King’s College London zone (VZ) [12, 13]. In the VZ, the neuronal precursors
change the position of their soma depending on whichGuy’s Campus
London SE1 1UL stage of the cell cycle they reside in. Thus, cells in G1
and G2 reside in the middle of the VZ, while S and M2 Cancer Research UK
London Research Institute phase cells are at the upper and lower boundary of the
VZ, respectively [13]. The position and morphology ofLincoln’s Inn Fields Laboratories
London WC2A 3PX the Pak1T212(PO4)-positive cells indicated that they
were undergoing mitosis. Neuronal precursors in otherUnited Kingdom
stages of the cell cycle were largely devoid of Pak1-
T212(PO4), despite having high expression levels of the
Pak1 protein (Figure 1A and data not shown). The mitoticSummary
marker, histone H3 phosphorylated on S10, revealed a
similar distribution of positively labeled cells (Figure 1B).The Pak kinases are targets of the Rho GTPases Rac
and Cdc42, which regulate cell shape and motility The specificity of the anti-Pak1T212(PO4) antibody, PK-
18, was verified for paraffin-embedded tissue by prein-[1–5]. It is increasingly apparent that part of this func-
tion is due to the effect Pak kinases have on microtu- cubation with a phosphorylated peptide, which effec-
tively abolished all positive staining (Figure 1C).bule organization and dynamics. Recently, overex-
pression of Xenopus Pak5 was shown to enhance To confirm these observations, we costained cryostat
sections of E19 rat cortices for Pak1T212(PO4) and phos-microtubule stabilization, and it was shown that mam-
malian Pak1 may inhibit a microtubule-destabilizing phorylated histone H3. In all cases, mitotic cells were
positive for both markers (Figure 1D). DNA labeling withprotein, Op18/Stathmin [6, 7]. We have identified a
specific phosphorylation site on mammalian Pak1, TOPRO3 revealed high levels of Pak1T212(PO4) during
prophase, metaphase, and anaphase (Figure 1E). In ad-T212, which is targeted by the neuronal p35/Cdk5 ki-
nase [8, 9]. Pak1 phosphorylated on T212, Pak1- dition to cortical progenitors, other cells in the CNS
were strongly positive for PK-18, particularly in the earlyT212(PO4), is enriched in axonal growth cones and
colocalizes with small peripheral bundles of microtu- stages of development. Their positions, for instance,
lining the lateral ventricle in the striatal, pallidal, andbules. Cortical neurons overexpressing a Pak1A212
mutant display a tangled neurite morphology, which hippocampal neuroepithelium, or surrounding the third
ventricle in the thalamic and hypothalamic neuroepithel-suggests that the microtubule cytoskeleton is affected
[9]. Here, we show that cyclin B1/Cdc2 phosphorylates ium (Figure 1A), frequently correlated with the mitotic
phase of the cell cycle. In the cortex, cells with upregu-Pak1 in cells undergoing mitosis. In the developing
cortex and in cultured fibroblasts, Pak1T212(PO4) is lated Pak1T212(PO4) were occasionally observed in
more superficial areas, where mitotic neuronal progeni-enriched in microtubule-organizing centers and along
parts of the spindles. In living cells, a peptide mimick- tors do not reside. These cells may be dividing radial
glia, since a similar frequency and distribution of phos-ing phosphorylated T212 accumulates at the centro-
somes and spindles and causes an increased length phohistone H3-stained cells was evident (Figures 1A
of astral microtubules during metaphase or following and 1B). PK-18-positive cells were also seen in other
nocodazole washout. Together these results suggest parts of the developing embryo where cells were prolif-
that similar signaling pathways regulate microtubule erating, such as the epithelial cells of the eye and gut
dynamics in a remodeling axonal growth cone and (Zhong and M.N., unpublished data), and their presence
during cell division. suggests that Pak1T212(PO4) is not restricted to the
nervous system but occurs in all mitotic cells.
Results and Discussion
Pak1T212(PO4) Accumulates in Microtubule-Pak1 Phosphorylation Is Seen in Neuronal
Organizing CentersPrecursors Undergoing Mitosis
Swiss3T3 fibroblasts in different stages of the cell cycleThe p35/Cdk5 kinase exclusively functions in postmi-
were examined for the presence of endogenous T212-totic cells, and the highest levels and activity are seen
phosphorylated Pak1. Interphase cells had very low lev-in neurons of the central nervous system (CNS), where
els of predominantly nuclear Pak1T212(PO4), whichthey regulate their migration and morphology [10, 11].
increased as cells entered prophase, initially in the nu-While examining the temporal and spatial pattern of
Pak1 phosphorylation in the developing cortex, we ob- cleus and subsequently throughout the cell (Figure 2A).
High levels of Pak1T212(PO4) persisted during meta-
phase, anaphase, and telophase and were subsequently3 Correspondence: margareta.nikolic@kcl.ac.uk
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Figure 1. Neuroepithelial Cells Accumulate Pak1T212(PO4) in M Phase
(A) A representative coronal section of paraffin-embedded mouse E12 brain, revealing positive cells lining the lateral and third ventricles, was
immunostained with an anti-Pak1T212(PO4) antibody, PK-18. The arrows point to striatal (S), pallidial (P), hippocampal (H), dentate gyrus (DG),
thalamic (T), and hypothalamic (HT) neuroepithelial cells in M phase.
(B) An adjacent section to (A) that reveals a similar distribution pattern of cells that are strongly positive for histone H3 phosphorylated on
S10. In (A) and (B), the insets show closer views of the developing cortex where M phase cortical progenitors and other mitotic cells are
marked with arrowheads and arrows, respectively.
(C) Preincubation of PK-18 with a phosphorylated peptide against which the antibody was raised, efficiently blocked all staining.
(D) A coronal section of a frozen E19 rat cortex that reveals neuronal progenitors in M phase that have upregulated both Pak1T212(PO4) and
the mitotic marker histone H3S10(PO4).
(E) Cortical progenitors in prophase (P), metaphase (M), and anaphase (A) that show high levels of Pak1T212(PO4). Staining with the DNA
marker TOPRO3 revealed their stage in mitosis. Images in (D) and (E) were obtained with an Olympus confocal microscope.
downregulated (Figure 2A). The distribution of Pak1- never been detected in proliferating cells [14–17]. Cdk5
is closely related to the cell cycle-promoting kinasesT212(PO4) was always punctate, similar to the pattern
seen in hippocampal neurons, especially their growth Cdc2 and Cdk2 with which it shares similar substrate
specificity [18–22]. The cyclin B1/Cdc2 kinase is essen-cones [9]. Interestingly, in all mitotic cells, Pak1-
T212(PO4) accumulated in two distinct points that ap- tial for the G2/M transition and passage through the first
half of M phase [23]. In interphase cells, it is largelypeared to be microtubule-organizing centers (MTOCs).
This was confirmed by colocalization with a centrosomal cytoplasmic, while, in prophase, it rapidly translocates
into the nucleus. It also accumulates in centrosomesmarker, -tubulin (Figure 2B). In vivo, in E19 rat cortices,
Pak1T212(PO4) also accumulated in MTOCs at either [24]. We compared the timing of Pak1 phosphorylation
and cyclin B1 expression in Swiss3T3 fibroblasts thatside of the spindles and colocalized with -tubulin (Fig-
ure 2C). were arrested in G0 and following the addition of serum
(4, 10, 16, and 26 hr when a fraction enriched with M
phase cells was harvested). The cell cycle profile of theCyclin B1/Cdc2 Catalyzes Pak1
Phosphorylation on T212 samples was determined by flow cytometry. The levels
of both cyclin B1 and Pak1T212(PO4) were low in G1 andDespite its ubiquitous expression, Cdk5 kinase activity
is primarily restricted to postmitotic neurons and has increased as more cells entered the G2 and M phases
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Figure 2. Pak1T212(PO4) Accumulates in MTOCs
(A) Swiss3T3 fibroblasts in prophase accumulated Pak1T212(PO4) in the nucleus and in two spots on either side of it. By metaphase,
Pak1T212(PO4) had spread out throughout the cytoplasm and was concentrated at the spindle poles. Its distribution remained the same
throughout anaphase and telophase, when it was downregulated. PK-18 (green), tyrosinated -tubulin (red), and TOPRO3 (blue). The arrows
point to MTOCs, and the arrowhead points to the nucleus of a cell in interphase.
(B) A representative Swiss3T3 fibroblast costained with PK-18 (red), the centrosomal marker -tubulin (green), and the DNA stain TOPRO3
(blue). The arrow points to the centrosome.
(C) Representative M phase neuronal progenitors in frozen E19 rat cortices that show accumulation of Pak1T212(PO4) in the area of the spindle
and in MTOCs, where it colocalizes with -tubulin. The arrows point to the spindles and centrosomes. All images were obtained with an
Olympus confocal microscope.
of the cell cycle, while Pak1 levels remained constant were fused to a stretch of arginines and tryptophans
(termed penetratin) that have previously been shown to(Figure 3A).
To determine if cyclin B1/Cdc2 catalyzes Pak1 phos- enter living cells due to their hydrophobic properties
and charge distribution [25, 26]. N-terminally conjugatedphorylation on T212, we carried out in vitro kinase
assays using a fragment of Pak1 (147–231) as a sub- biotin enabled us to examine the subcellular localization
of the peptides using FITC-conjugated streptavidine.strate. Cyclin B1 immunoprecipitates from Cos7 cells
phosphorylated the 147–231 fragment, not the same In interphase cells, the peptides distributed uniformly
throughout the cell. However, in mitosis, the phosphory-region containing a T212A mutation (Figure 3B). Cdk2
immunoprecipitates failed to phosphorylate 147–231, lated peptide accumulated along the length of the spin-
dles and in their poles (Figure 4A). This was especiallydespite the clear presence of kinase activity, as deter-
mined by histone H1 phosphorylation. p35 immunopre- evident in metaphase cells. The unphosphorylated pep-
tide was less efficiently transported to the spindles,cipitates were used as a positive control. Cyclin B1/
Cdc2 also phosphorylated full-length Pak1 on T212, as while cells that were not exposed to peptides had no
detectable streptavidine staining. These results suggestdetermined by a nonradioactive kinase assay (Fig-
ure 3C). that phosphorylated T212 is part of a protein binding site
that targets Pak1 to areas of microtubule organization.
T212 Phosphorylation Targets Pak1 to MTOCs
To address the biological role of Pak1T212(PO4) during Pak1T212(PO4) Regulates the Organization
of Dynamic Microtubulesmitosis, we generated small peptides containing 15
amino acids that were identical to the sequence sur- We used the peptides to address the functional sig-
nificance of Pak1 phosphorylation during mitosis.rounding the T212 site of Pak1, and one of the peptides
was synthesized with a phosphate group on T212. These Swiss3T3 fibroblasts were treated for 3 hr with the mi-
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Figure 3. Cyclin B1/Cdc2 Phosphorylates
Pak1 on T212
(A) Western blots of lysates obtained from
Swiss3T3 fibroblasts that had been starved
(0) and following serum addition at 4, 10, and
16 hr (the M fraction marks mitotic shakeoff
at 26 hr). An induction of cyclin B1 expression
and Pak1T212(PO4) was seen as more cells
entered the G2/M phase. The cell cycle profile
of each sample was determined by flow cy-
tometry.
(B) Immunoprecipitates of endogenous cyclin
B1 phosphorylated a recombinant fragment
of Pak1 (147–231) in a similar manner to the
p35/Cdk5 kinase that had been obtained from
overexpressing Cos7 cells. In both cases, this
was prevented by a T212A mutation. Cdk2
immunoprecipitates were only seen to phos-
phorylate histone H1. Note that the p35/Cdk5
kinase also phosphorylates p35.
(C) Cyclin B1 immunoprecipitates phosphor-
ylated in vitro full-length, kinase-inactive re-
combinant GST-Pak1R299 and GST-147–
231, but not GST, as determined by PK-18
Western blots. In (B) and (C), the right panels
are Coomassie stained gels showing the lev-
els of the substrates used.
crotubule-depolymerizing drug nocodazole. The phos- the phosphorylated peptide had more than half of their
areas filled with microtubules. The fixation of cells atphorylated or unphosphorylated peptides were added
during the last 30 min of nocodazole treatment, subse- earlier times after nocodazole washout (30 s or 1 min)
revealed that most cells in all the treatment groups werequent to which the cells were washed and allowed to
recover for 2 min. In the controls, an antibody to tyrosin- able to nucleate microtubules. However, in many cases,
exposure to the phosphorylated peptide induced extraated -tubulin revealed newly formed microtubules that
extended from one or two MTOCs located close to the microtubules outside the main nucleation center and
the appearance of many free, nontethered microtubulesnucleus toward the cell peripheries (Figure 4B). Remark-
ably, in cells treated with the phosphorylated peptide, located at the cell peripheries (46% of cells) (Figure 3B).
This was far less common in the control samples (nomicrotubules often appeared to be disorganized and
extended much further toward the cell edges (Figure peptide, 17%; and unphosphorylated peptide, 13%). A
peptide with a T212A mutation gave a similar phenotype4B). Since it was not possible to accurately estimate
their length, the area within a cell that contained microtu- to the unphosphorylated peptide (Figure 3B and data
not shown).bules was compared to its overall size. A total of 100
cells were examined for each treatment group, and all
scoring was performed blind. Similar results were ob- Pak1T212(PO4) Regulates Astral Microtubules
in Metaphase Cellstained from three separate experiments. Following 2 min
of recovery, 22% of the untreated and 33% of cells We next determined if the distribution of microtubules
was affected by the phosphorylated peptides during cellexposed to the unphosphorylated peptide contained
microtubules that had spread over more than half of the division. Swiss3T3 fibroblasts approaching mitosis were
treated for 2 hr with the peptides prior to fixation. Expo-cell area. In contrast, 55% of the Swiss3T3s treated with
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Figure 4. Pak1T212(PO4) Affects Microtubule Organization during Mitosis
(A) The subcellular localization of biotin-conjugated penetratin peptides containing 15 amino acids surrounding T212 was examined with FITC-
streptavidine. The top panel shows no background staining, and the middle panel shows the localization of the nonphosphorylated peptide.
Phosphorylation of T212 directs the peptides to the spindles and MTOCs of metaphase cells (lower panel).
(B) Swiss3T3 fibroblasts that have been treated with nocodazole have completely depolymerized microtubules (top left panel). A total of 1 or
2 min after nocodazole removal, microtubules extended from an organization center in the controls (no peptide), in the presence of A212 or
unphosphorylated peptides. Exposure to the phosphorylated peptide induced the formation of nonattached microtubules (arrows at 1 min of
recovery) and greater length and disorganization (2 min). A white line outlines the cells.
(C) A Swiss3T3 fibroblast in metaphase that shows normal spindle organization in untreated cells (top panel) and after incubation with the
unphosphorylated peptide (middle panel). The bottom panel shows the increase in the length of astral microtubules that is seen after exposure
to the phosphorylated peptide. The right panel is an overlay showing microtubules (green), centrosomes (-tubulin; red), and DNA (blue).
(D) Swiss3T3s in metaphase that have been extracted with 0.5% Triton X-100 prior to fixation to remove cytoplasmic proteins. A proportion
of Pak1 remains associated with the spindles in the control (no peptide), A212, and unphosphorylated peptide treatments. Exposure to the
phosphorylated peptide reduced the levels of spindle-associated Pak1. All images were obtained with an Olympus confocal microscope.
sure to the phosphorylated peptide increased the num- 16% and 8% of cells exposed to unphosphorylated or
no peptides, respectively. Equivalent measurements ofber and length of astral microtubules that extended from
the MTOCs (Figure 4C). The areas containing astral mi- the spindles revealed no significant differences between
the three treatments. Similar results were obtained fromcrotubules were measured for each metaphase cell, and
the average size of the measured areas was divided by four separate experiments. Prolonged exposure to the
peptides (up to 4 hr) did not appear to affect cell division.the overall cell size. Many cells (38%) that had been
treated with the phosphorylated peptide had prominent Since the phosphorylated peptide is targeted to the
spindles, it is probable that it acts as a dominant nega-astral microtubules that extended throughout more than
a tenth of the soma. This proportion was reduced to tive by competing with endogenous Pak1. To date, an
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and antibodies were diluted in 2% normal goat serum in PBS con-association between Pak1 and microtubules has not
taining 0.2% Tween 20.been shown. We therefore extracted Swiss3T3 fibro-
blasts with detergent prior to fixation in order to remove
Cell Scoring
cytoplasmic proteins. Subsequent staining with anti- Scoring was carried out blind with a Zeiss Axioscop microscope at
Pak1 antibodies revealed that a small subpopulation of 40 and a macro provided by Imaging Associates. The macro en-
this kinase remained tightly bound to the mitotic spin- abled the outlining of individual cells and areas within as well as
the calculation of the surface areas.dles. A 1-hr treatment with unphosphorylated or A212
peptides had no effect on the amount of Pak1 retained
Kinase Assayson the spindles. In contrast, exposure to the phosphory-
Kinase assays were carried out as previously described for p35/lated peptide reduced the pool of microtubule-bound
Cdk5 [8]. The substrates were histone H1, or fragments of Pak1
Pak1 (Figure 4D). We have also observed significant that had been purified from Escherichia coli and the GST tag was
levels of the phosphorylated peptide tightly bound to the removed by cleavage with thrombin, or GST-Pak1R299 [16].
cytoskeleton, and this finding suggests that it competes
Acknowledgmentswith endogenous Pak1 for microtubule association (data
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